{"id":"imprimis-dropless","safety":{"commonSideEffects":[{"rate":null,"effect":"Corneal edema"},{"rate":null,"effect":"Elevated intraocular pressure"},{"rate":null,"effect":"Anterior chamber inflammation"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This is a customized, preservative-free compounded medication that integrates corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs), and antibiotics into a single formulation. It is injected into the eye during cataract surgery to provide sustained therapeutic levels throughout the post-operative period, eliminating the need for patients to instill multiple topical drops at home.","oneSentence":"Imprimis Dropless is a compounded ophthalmic formulation combining multiple anti-inflammatory and antimicrobial agents to prevent infection and inflammation following cataract surgery without requiring separate post-operative eye drops.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:48:16.148Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of post-operative inflammation and infection following cataract surgery"}]},"trialDetails":[{"nctId":"NCT02819908","phase":"PHASE4","title":"Dropless™ vs. Less Drops™ Pharmaceutical Regimens After Cataract Surgery","status":"COMPLETED","sponsor":"Eye Center of North Florida","startDate":"2015-09","conditions":"Intraocular Lens Associated Postoperative Inflammation","enrollment":25}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Imprimis Dropless","genericName":"Imprimis Dropless","companyName":"Eye Center of North Florida","companyId":"eye-center-of-north-florida","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Imprimis Dropless is a compounded ophthalmic formulation combining multiple anti-inflammatory and antimicrobial agents to prevent infection and inflammation following cataract surgery without requiring separate post-operative eye drops. Used for Prevention of post-operative inflammation and infection following cataract surgery.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}